Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung

Carcinogenesis

Volumn 31, Issue 10, 2010, Pages 1833-1843

  Satoh, Hironori ^a   Moriguchi, Takashi ^a   Taguchi, Keiko ^a   Takai, Jun ^a   Maher, Jonathan M ^a   Suzuki, Takafumi ^a   Winnard Jr , Paul T ^b   Raman, Venu ^b   Ebina, Masahito ^a   Nukiwa, Toshihiro ^a   Yamamoto, Masayuki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; REACTIVE OXYGEN METABOLITE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NRF2; NFE2L2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CD8+ T LYMPHOCYTE; CELL FRACTIONATION; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; FLUORESCENCE; HEMATOPOIETIC CELL; HISTOPATHOLOGY; IMMUNE SYSTEM; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEWIS CARCINOMA; LUNG CANCER; LUNG METASTASIS; LUNG NODULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; SUPPRESSOR CELL; TRANSCRIPTION FACTOR NRF2 DEFICIENCY; TUMOR MICROENVIRONMENT; WILD TYPE; ANIMAL; C57BL MOUSE; CYTOLOGY; DEFICIENCY; HEMATOPOIETIC SYSTEM; LUNG TUMOR; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; SECONDARY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; HEMATOPOIETIC SYSTEM; IMMUNE SYSTEM; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 77957796093     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq105     Document Type: Article

References (33)

1. Itoh, K. et al. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun., 236, 313-322.
2. Motohashi, H. et al. (2004) Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Natl Acad. Sci. USA, 101, 6379-6384.
3. Itoh, K. et al. (2003) Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells, 8, 379-391.
4. Kobayashi, A. et al. (2004) Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol., 24, 7130-7139.
5. Iida, K. et al. (2007) Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis. Carcinogenesis, 28, 2398-2403.
6. Kasai, H. et al. (2006) Oxidative DNA damage: mechanisms and significance in health and disease. Antioxid. Redox Signal., 8, 981-983.
7. Ostrand-Rosenberg, S. et al. (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol., 182, 4499-4506.
8. Nagaraj, S. et al. (2007) Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat. Med., 13, 828-835.
9. Sato, T. et al. (1989) Conversion of Lewis lung carcinoma into ascitic form. Oncology, 46, 188-192.
10. Poste, G. et al. (1980) In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res., 40, 1636-1644.
11. Winnard, P.T. Jr. et al. (2006) Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer. Neoplasia, 8, 796-806.
12. Stoner, G.D. et al. (1973) Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice. Cancer Res., 33, 3069-3085.
13. Okada, K. et al. (2008) Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am. J. Physiol. Gastrointest. Liver Physiol., 295, G735-G47.
14. Sinha, P. et al. (2008) Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol., 181, 4666-4675.
15. Nefedova, Y. et al. (2007) Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Res., 67, 11021-11028.
16. Kim, H.J. et al. (2008) Nrf2 activation by sulforaphane restores the agerelated decrease of T(H)1 immunity: role of dendritic cells. J. Allergy Clin. Immunol., 121, 1255-1261e7.
17. Dignam, J.D. et al. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
18. Watai, Y. et al. (2007) Subcellular localization and cytoplasmic complex status of endogenous Keap1. Genes Cells, 12, 1163-1178.
19. Kyhse-Andersen, J. (1984) Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J. Biochem. Biophys. Methods, 10, 203-209.
20. Aoki, Y. et al. (2001) Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharmacol., 173, 154-160.
21. Nguyen, T. et al. (2003) Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol., 43, 233-260.
22. Ishii, Y. et al. (2005) Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J. Immunol., 175, 6968-6975.
23. Thimmulappa, R.K. et al. (2006) Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest., 116, 984-995.
24. Nagaraj, S. et al. (2008) Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res., 68, 2561-2563.
25. Shojaei, F. et al. (2008) Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells. Cancer Res., 68, 5501-5504.
26. Khor, T.O. et al. (2008) Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer. Cancer Prev. Res. (Phila. Pa), 1, 187-191.
27. Ramos-Gomez, M. et al. (2001) Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl Acad. Sci. USA, 98, 3410-3415.
28. Xu, C. et al. (2006) Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res., 66, 8293-8296.
29. Ohta, T. et al. (2008) Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res., 68, 1303-1309.
30. Padmanabhan, B. et al. (2006) Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell, 21, 689-700.
31. Shibata, T. et al. (2008) Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology, 135, 1358-13681368 e1-4.
32. Shibata, T. et al. (2008) Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl Acad. Sci. USA, 105, 13568-13573.
33. Singh, A. et al. (2006) Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med., 3, e420.